Year: 2004
Type: article
Abstract: For older populations, most of whom are women, preventing illnesses and deaths through the use of vaccines is a leading public health challenge.Our understanding about how age and sex affect the immune system is limited, and basic and translational research aimed at improving vaccines and immune responses of older persons is needed.In the meantime, fully implementing current vaccine recommendations, particularly those for influenza and pneumococcal vaccines, can save thousands of lives and prevent illnesses in persons >50 years of age.I n the United States, the elderly are more likely to die of a vaccine-preventable disease.Adult deaths from influenza (≈36,000/y) (1,2), invasive pneumococcal disease (≈9,000/y) (3), and hepatitis B (≈5,000/y) (4) exceed vaccine-preventable deaths among children (≈50/y) by a ratio of ≈1,000:1.For each of these diseases, case-fatality rates rise with increasing age.This disparity can be addressed through adult vaccination programs, which are cost-effective and life-saving.Women constitute most of the adult U.S. population >50 years of age (60% of those 75 years of age and 70% of those 85 years of age).The immune system does not function as well with advancing age (5).For example, T-cell functions diminish with age, as evidenced by the increased prevalence of anergy to mycobacterial and fungal skin-test antigens and the increased frequency and severity of herpes zoster infection with age.B-cell function diminishes, as seen with the lessened humoral response (immunoglobulin [Ig] M, IgG, and IgA) to certain vaccines (e.g., hepatitis B, influenza, pneumococcal vaccine), and the protective efficacy of these vaccines also decreases as recipients age (6,7).
Source: Emerging infectious diseases
Authors: Pierce Gardner, Sudha Pabbatireddy
Language: English
Subfield: Immunology
Field: Immunology and Microbiology
Domain: Life Sciences
Open Access status: diamond
OpenAlex ID: W2087669330
